Ventricular assist device, an 'artificial heart', gains ground in Catalan patients

This technique, serving as a bridge to transplantation or a definitive therapy, is expected to increase due to population aging.

Generic image of an artificial heart or ventricular assist device.
IA

Generic image of an artificial heart or ventricular assist device.

The ventricular assist device technique, known as an 'artificial heart', is becoming a consolidated treatment option for heart failure patients in Catalonia, with a significant increase expected in the coming years.

Cardiology experts warn that the incidence of heart failure will continue to rise, driven by population aging and exposure to risk factors such as obesity, diabetes, hypertension, and high cholesterol. This situation has led to the disease being considered a

"pandemic that will intensify in the coming years"

a cardiologist
This technique, functioning as an 'artificial heart', can be a definitive solution or an intermediate step towards a transplant. Currently, two patients from the Lleida region are already receiving this assistance, with coordinated follow-up between hospitals in Lleida and Barcelona for the past two years. The number of patients benefiting from this technology is expected to increase significantly.
In addition to ventricular assist devices, a larger group of patients uses devices such as pacemakers or defibrillators. Continuous research is fundamental for the development of new drugs and for improving early detection and treatment of these cardiac pathologies.